Literature DB >> 16697746

NAFLD, obesity, and bariatric surgery.

Paul Angulo1.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16697746     DOI: 10.1053/j.gastro.2006.03.041

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  25 in total

1.  Treatment options for nonalcoholic Fatty liver disease.

Authors:  Shivakumar Chitturi
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

2.  Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.

Authors:  Xianjun Luo; Honggui Li; Linqiang Ma; Jing Zhou; Xin Guo; Shih-Lung Woo; Ya Pei; Linda R Knight; Michael Deveau; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Xiangbai Chen; Yuqing Huo; Kelly McDaniel; Heather Francis; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Chaodong Wu
Journal:  Gastroenterology       Date:  2018-09-10       Impact factor: 22.682

3.  Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.

Authors:  Géraldine Gentric; Vanessa Maillet; Valérie Paradis; Dominique Couton; Antoine L'Hermitte; Ganna Panasyuk; Bernard Fromenty; Séverine Celton-Morizur; Chantal Desdouets
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

4.  The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

Authors:  Sombat Treeprasertsuk; Scott Leverage; Leon A Adams; Keith D Lindor; Jennifer St Sauver; Paul Angulo
Journal:  Liver Int       Date:  2012-02-02       Impact factor: 5.828

Review 5.  Unbalanced oxidant-antioxidant status and its effects in pediatric diseases.

Authors:  Valentina Chiavaroli; Cosimo Giannini; Stefania De Marco; Francesco Chiarelli; Angelika Mohn
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

6.  The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity.

Authors:  Melania Manco; José Manuel Fernandez-Real; Fabio Maria Vecchio; Valerio Vellone; José María Moreno; Vincenzo Tondolo; GianFranco Bottazzo; Giuseppe Nanni; Geltrude Mingrone
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

7.  Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

Authors:  Dima L Diab; Lisa Yerian; Philip Schauer; Sangeeta R Kashyap; Rocio Lopez; Stanley L Hazen; Ariel E Feldstein
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-26       Impact factor: 11.382

8.  Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.

Authors:  Marianna Argentou; Dina G Tiniakos; Menelaos Karanikolas; Maria Melachrinou; Maria G Makri; Christos Kittas; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2009-07-15       Impact factor: 4.129

Review 9.  Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.

Authors:  Vikas Khullar; Angela Dolganiuc; Roberto J Firpi
Journal:  World J Transplant       Date:  2014-06-24

10.  Metabolic syndrome and insulin resistance in subjects with morbid obesity.

Authors:  Valentina Soverini; Simona Moscatiello; Nicola Villanova; Elisabetta Ragni; Silvia Di Domizio; Giulio Marchesini
Journal:  Obes Surg       Date:  2009-10-20       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.